Markets.com Logo

BIOIF

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.0005$
  • Previous Close
    0.0005$
  • 52 Week Change
    0.01$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.0005$ - 0.0118$
  • Dividend Per Share
    --
  • Market cap
    406 K$
  • EPS
    -0.0013
  • Beta
    -1.628
  • Volume
    --

About

BIOIF.US represents Biofrontera Inc., a biopharmaceutical company specializing in the development and commercialization of dermatological products, particularly those focused on the treatment of skin cancer and related conditions. The company's key product is Ameluz, a prescription drug used in combination with photodynamic therapy (PDT) for the treatment of actinic keratoses, a common precancerous skin lesion. Biofrontera Inc. also develops and markets other dermatological products through its subsidiaries.

US Monetary Policy Pivot: Non-Farm Payrolls, Inflation Fears, and Potential Rate Hikes

Emma Rose|--

Netanyahu-Trump Rift Exposed: Ceasefire Talks Put Israeli Election Stakes in Jeopardy

Sophia Claire|--

US May Jobs Report: A Critical Indicator for the Fed's Interest Rate Path

Liam James|--

AI Bubble Risks and Market Correction: Insights from TS Lombard

Liam James|--

Global Market Indicators and Trading Strategy Updates: June 5, 2026

Ava Grace|--

Quantinuum Sets IPO Price at $60 Per Share, Igniting Investor Interest in Quantum Computing

Noah Lee|--

Fed's Interest Rate Outlook Faces Major Shift: Is a Policy Tightening Ahead?

Ava Grace|--

Factors

Here's information about factors that affect BIOIF.US stock price: Company Performance: Positive earnings reports, successful clinical trials, and new product launches typically drive the stock price up. Conversely, losses or clinical trial failures can lower it. Industry Trends: Developments in the biotechnology industry, such as new technologies or increased regulatory scrutiny, impact investor sentiment and the stock's valuation. Market Conditions: Broader market factors like economic growth, interest rates, and overall investor confidence influence trading activity and affect stock prices, including BIOIF.US. Regulatory Environment: Changes in regulations related to drug approvals or healthcare policies can have a significant impact on BIOIF.US, especially if the company is developing or selling regulated products. Competition: The competitive landscape in the biopharmaceutical sector affects market share and profitability, directly impacting BIOIF.US's perceived value and thus, its stock price. News and Announcements: Company-specific news, press releases, or announcements about partnerships, acquisitions, or research breakthroughs affect the market's perception and trading activity. Investor Sentiment: Investor sentiment and overall market psychology regarding the biotech industry and the specific company can cause rapid price fluctuations, regardless of fundamentals.

People Also Watch

Latest news

Market Pulse: Dollar Rises, Gold Dips Post-US Jobs Data; Geopolitical Tensions Simmer

Noah Lee|--

US May Jobs Report Signals Slowing Growth: A Deep Dive into Market Indicators

Sophia Claire|--

Hormuz Strait Oil Tanker Activity Shifts: Increased Secrecy and Market Fragmentation

Sophia Claire|--

Latest Education Articles

Top 15 Forex Chart Patterns You Need to Know

Top 15 Forex Chart Patterns You Need to Know

Julian Parker|--
3-5-7 Rule in Trading: How It Works, Examples and Risks

3-5-7 Rule in Trading: How It Works, Examples and Risks

Julian Parker|--
What Is a Protective Put? Strategy, Cost & When to Use It

What Is a Protective Put? Strategy, Cost & When to Use It

Julian Parker|--
Recommended Topics